Artesunate: a potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma DOI Creative Commons
Xinyue Liu, Yilin Cai, Yuanhao Zhang

et al.

Pharmacological Research, Journal Year: 2024, Volume and Issue: unknown, P. 107526 - 107526

Published: Nov. 1, 2024

Language: Английский

Drug Delivery Opportunities in Esophageal Cancer: Current Treatments and Future Prospects DOI
Robert C. Sabatelle, Yolonda L. Colson, Uma M. Sachdeva

et al.

Molecular Pharmaceutics, Journal Year: 2024, Volume and Issue: 21(7), P. 3103 - 3120

Published: June 18, 2024

With one of the highest mortality rates all malignancies, 5-year survival rate for esophageal cancer is under 20%. Depending on stage and extent disease, current standard care treatment paradigm includes chemotherapy or chemoradiotherapy followed by surgical esophagogastrectomy, with consideration adjuvant immunotherapy residual disease. This regimen has high morbidity, due to anatomic changes inherent in surgery, acuity complications, off-target effects systemic immunotherapy. We begin a review treatments, then discuss new emerging targets therapies advanced drug delivery systems. Recent ongoing preclinical early clinical studies are evaluating traditional tumor (e.g., human epidermal growth factor receptor 2), as well promising such Yes-associated protein 1 mammalian target rapamycin develop treatments this Due function location esophagus, opportunities also exist pair these strategy increase targeting, bioavailability, intratumor concentrations, two most common platforms being stents nanoparticles. Finally, results antibody conjugates chimeric antigenic T cells show promise upcoming therapies. discusses innovations therapeutics context their successes failures, goal identifying those solutions that demonstrate shift treating deadly

Language: Английский

Citations

4

Neurological Emergency Treatment Strategy: A Neuron-Targeted Regulation System for Reactive Oxygen Species Metabolism through Ferroptosis Modulation DOI

Yibo Ying,

Xiong Cai,

Peng Dai

et al.

ACS Nano, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 25, 2025

Spinal cord injury (SCI) represents a significant clinical challenge. Following SCI, the implementation of protective measures for neurons is critically important. Current applications hormone pulse therapy exhibit variable efficacy and considerable side effects, highlighting an urgent need therapeutic strategies. This study investigates pathological conditions ischemia hypoxia in SCI region, complemented by early transcriptome sequencing postinjury. Our findings suggest that targeting ferroptosis pivotal neuroprotection following SCI. Aiming at cascade effect mitochondrial damage leading to reactive oxygen species (ROS) production, along with extensive ROS-mediated lysosomal during signaling, we developed liposome-based system regulating iron metabolism─DTLS@CAT. innovative liposome designed specifically target neuronal mitochondria, effectively eliminate mitoROS, modulate complex interactions among metabolism, lysosomes, ROS facilitate recovery from

Language: Английский

Citations

0

Faberidilactone A, a Sesquiterpene Dimer, Inhibits Hepatocellular Carcinoma Progression Through Apoptosis, Ferroptosis, and Anti-Metastatic Mechanisms DOI Creative Commons

Ruyu Cao,

Yuhui Liu, Jiahe Bao

et al.

Molecules, Journal Year: 2025, Volume and Issue: 30(5), P. 1095 - 1095

Published: Feb. 27, 2025

Cancer remains a significant global public health challenge, with hepatocellular carcinoma (HCC) ranking among the top five malignancies in terms of mortality. Faberidilactone A, sesquiterpenoid dimer isolated from Inula japonica, exhibits potent cytotoxicity against various human tumor cell lines and demonstrates remarkable antitumor potential. In vitro studies using HepG2 cells revealed that faberidilactone A induces apoptosis ferroptosis, causes cycle arrest, enhances production intracellular reactive oxygen species (ROS), disrupts mitochondrial function. Mechanistic investigations via Western blot analysis indicated impedes proliferation by modulating signal transducer activator transcription 3 (STAT3) signaling pathway inhibits metastasis affecting focal adhesion kinase (FAK) pathway. vivo experiments zebrafish model demonstrated effectively suppresses dissemination anti-angiogenic properties. When concentration reached 10 µM, inhibition rates proliferation, migration, intersegmental vessels (ISVs) length were 76.9%, 72.6%, 46.2%, respectively. These findings underscore therapeutic potential as promising agent for HCC treatment.

Language: Английский

Citations

0

Nanobiotechnology boosts ferroptosis: opportunities and challenges DOI Creative Commons

Shiqi Han,

Jianhua Zou,

Fan Xiao

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Oct. 8, 2024

Ferroptosis, distinct from apoptosis, necrosis, and autophagy, is a unique type of cell death driven by iron-dependent phospholipid peroxidation. Since ferroptosis was defined in 2012, it has received widespread attention researchers worldwide. From biochemical perspective, the regulation strongly associated with cellular metabolism, primarily including iron lipid redox metabolism. The distinctive regulatory mechanism holds great potential for overcoming drug resistance-a major challenge treating cancer. considerable role nanobiotechnology disease treatment been widely reported, but further more systematic discussion on how enhances therapeutic efficacy ferroptosis-associated diseases still needs to be improved. Moreover, while exciting cancer relatively well summarized, its applications other diseases, such as neurodegenerative cardiovascular cerebrovascular kidney disease, remain underreported. Consequently, necessary fill these gaps complete ferroptosis. In this review, we provide an extensive introduction background elaborate network. Subsequently, discuss various advantages combining enhance reduce side effects diseases. Finally, analyze feasibility improving clinical outcomes based needs, current limitations future directions ferroptosis, which will not only significant guidance also accelerate their translations.

Language: Английский

Citations

3

FeS embedded bioreactor collaborate with artesunate for cascade-catalytic tumor ferroptosis DOI
Xiaoyu Wang, Chunming Xu, Hui Tian

et al.

Journal of Colloid and Interface Science, Journal Year: 2025, Volume and Issue: unknown, P. 137479 - 137479

Published: March 1, 2025

Language: Английский

Citations

0

Traditional Chinese medicine-based drug delivery systems for anti-tumor therapies DOI
Ling Yang,

Ya‐Lei Wang,

Xietao Ye

et al.

Chinese Journal of Natural Medicines, Journal Year: 2024, Volume and Issue: 22(12), P. 1177 - 1192

Published: Dec. 1, 2024

Language: Английский

Citations

2

Novel Strategies for Tumor Treatment: Harnessing ROS-Inducing Active Ingredients from Traditional Chinese Medicine Through Multifunctional Nanoformulations DOI Creative Commons
Zhengguang Zhang, M. Y. Li,

Xiaolong Zhang

et al.

International Journal of Nanomedicine, Journal Year: 2024, Volume and Issue: Volume 19, P. 9659 - 9688

Published: Sept. 1, 2024

Reactive oxygen species (ROS) encompass a diverse group of chemically reactive molecules or ions distinguished by their substantial oxidative potential. Empirical studies have shown that the targeted administration high toxic concentrations ROS can effectively induce tumor cell death in various types. Numerous bioactive ingredients derived from traditional Chinese medicine (TCM), recognized for ROS-inducing properties, demonstrated significant anti-tumor activity. Nonetheless, clinical application has been hindered challenges such as low solubility, limited bioavailability, and poor selectivity. Multifunctional nanoformulations possess potential to overcome these enhance anticancer efficacy active compounds. Through extensive searches academic databases thorough review screening relevant literature, this study aims systematically summarize generalize multiple TCM generation, along with multifunctional nanoformulations, perspectives. The objective is provide new insights references fundamental cancer research treatments. Furthermore, we acknowledge although numerous potentials, potentially offering novel strategies therapy, underlying mechanisms require further comprehensive investigation.

Language: Английский

Citations

1

[Ferroptosis suppressor genes are highly expressed in esophageal cancer to inhibit tumor cell ferroptosis]. DOI
Yan Wang, Peng Zhang

PubMed, Journal Year: 2024, Volume and Issue: 44(7), P. 1389 - 1396

Published: July 20, 2024

To explore the role of ferroptosis-related genes in regulating ferroptosis esophageal squamous cell carcinoma (ESCC).

Language: Английский

Citations

0

The association between N-nitrosamines exposure and lipid metabolism in the high incidence area of esophageal cancer: A case-control analysis DOI
Hu Zhang, Chao Zhao,

Yucheng Wang

et al.

Environmental Pollution, Journal Year: 2024, Volume and Issue: 363, P. 125271 - 125271

Published: Nov. 7, 2024

Language: Английский

Citations

0

Artesunate: a potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma DOI Creative Commons
Xinyue Liu, Yilin Cai, Yuanhao Zhang

et al.

Pharmacological Research, Journal Year: 2024, Volume and Issue: unknown, P. 107526 - 107526

Published: Nov. 1, 2024

Language: Английский

Citations

0